Godrej Agrovet Limited (BOM:540743)
India · Delayed Price · Currency is INR 815.50
+2.85 (0.35%)
At close: Aug 8, 2025
Inozyme Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 4,297 | 3,597 | 3,019 | 4,026 | 3,137 | Upgrade |
Depreciation & Amortization | - | 2,261 | 2,143 | 1,826 | 1,706 | 1,513 | Upgrade |
Other Amortization | - | - | - | 28.8 | 27.7 | 26.7 | Upgrade |
Loss (Gain) From Sale of Assets | - | 45.2 | 30 | -694.2 | 32.9 | -1.3 | Upgrade |
Asset Writedown & Restructuring Costs | - | 14.1 | -70.6 | -30.5 | 11.8 | 9 | Upgrade |
Loss (Gain) From Sale of Investments | - | -2 | -0.7 | -0.3 | - | -1 | Upgrade |
Loss (Gain) on Equity Investments | - | -535.7 | -520.4 | -319.8 | -502.1 | -502.4 | Upgrade |
Stock-Based Compensation | - | 21.9 | 32.2 | 30.4 | 28.2 | 20.5 | Upgrade |
Provision & Write-off of Bad Debts | - | 75.2 | 279.2 | 312.6 | 569.2 | 469.1 | Upgrade |
Other Operating Activities | - | 947.8 | 822.8 | 652.7 | -14.8 | 637.4 | Upgrade |
Change in Accounts Receivable | - | -632.1 | 265.5 | 3,461 | -1,829 | -202.2 | Upgrade |
Change in Inventory | - | 1,195 | -415 | 569 | -4,484 | -938.8 | Upgrade |
Change in Accounts Payable | - | 2,631 | -732.6 | 129.7 | -824.8 | -4,988 | Upgrade |
Change in Other Net Operating Assets | - | -625.6 | 1,350 | -243.8 | 52.8 | 716.2 | Upgrade |
Operating Cash Flow | - | 9,693 | 6,780 | 8,740 | -1,201 | -104.2 | Upgrade |
Operating Cash Flow Growth | - | 42.97% | -22.43% | - | - | - | Upgrade |
Capital Expenditures | - | -2,247 | -3,844 | -3,592 | -2,710 | -2,473 | Upgrade |
Sale of Property, Plant & Equipment | - | 130.4 | 75.2 | 798.9 | 30.6 | 67 | Upgrade |
Cash Acquisitions | - | - | - | - | 420.8 | - | Upgrade |
Investment in Securities | - | 232.1 | 4.2 | 72.1 | -165.8 | -8.7 | Upgrade |
Other Investing Activities | - | 808.3 | 581.2 | 184.5 | 344.2 | 627.3 | Upgrade |
Investing Cash Flow | - | -815.3 | -3,273 | -2,843 | -2,081 | -1,787 | Upgrade |
Short-Term Debt Issued | - | 80,980 | 61,086 | 52,133 | 48,184 | 21,250 | Upgrade |
Long-Term Debt Issued | - | 2,024 | 2,861 | 1,028 | 320.2 | 1,595 | Upgrade |
Total Debt Issued | - | 83,004 | 63,947 | 53,161 | 48,504 | 22,845 | Upgrade |
Short-Term Debt Repaid | - | -82,844 | -63,161 | -54,916 | -41,586 | -19,066 | Upgrade |
Long-Term Debt Repaid | - | -750.6 | -1,213 | -843.5 | -1,278 | -337.1 | Upgrade |
Total Debt Repaid | - | -83,595 | -64,374 | -55,760 | -42,864 | -19,403 | Upgrade |
Net Debt Issued (Repaid) | - | -591.1 | -427.3 | -2,599 | 5,641 | 3,442 | Upgrade |
Issuance of Common Stock | - | 0.6 | 0.5 | 0.5 | 0.4 | 0.3 | Upgrade |
Common Dividends Paid | - | -1,923 | -1,825 | -1,825 | -1,536 | -1,056 | Upgrade |
Other Financing Activities | - | -6,495 | -1,024 | -1,520 | -996.4 | -495.4 | Upgrade |
Financing Cash Flow | - | -9,008 | -3,276 | -5,944 | 3,108 | 1,891 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0.3 | Upgrade |
Net Cash Flow | - | -130.3 | 230.4 | -46.4 | -172.7 | -1.2 | Upgrade |
Free Cash Flow | - | 7,447 | 2,936 | 5,148 | -3,911 | -2,577 | Upgrade |
Free Cash Flow Growth | - | 153.62% | -42.96% | - | - | - | Upgrade |
Free Cash Flow Margin | - | 7.94% | 3.08% | 5.50% | -4.71% | -4.12% | Upgrade |
Free Cash Flow Per Share | - | 38.72 | 15.27 | 26.78 | -20.35 | -13.41 | Upgrade |
Cash Interest Paid | - | 1,219 | 1,014 | 955.9 | 601.6 | 430.1 | Upgrade |
Cash Income Tax Paid | - | 1,465 | 1,237 | 933.2 | 1,533 | 1,123 | Upgrade |
Levered Free Cash Flow | - | 5,659 | 1,895 | 4,529 | -4,989 | -3,794 | Upgrade |
Unlevered Free Cash Flow | - | 6,484 | 2,562 | 5,139 | -4,603 | -3,512 | Upgrade |
Change in Working Capital | - | 2,569 | 467.9 | 3,916 | -7,085 | -5,413 | Upgrade |
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.